COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 2.920
+0.180 (6.57%)
At close: Feb 9, 2026
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 8.72 million as of February 9, 2026. Its market cap has increased by 26.03% in one year.
Market Cap
8.72M
Enterprise Value
-126.71K
Revenue
12.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.92
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 14.82B to 8.72M, a decrease of -99.94%. That is a compound annual growth rate of -22.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 8.72M | -3.52% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lobe Sciences | 13.47M |
| Pharmala Biotech Holdings | 10.89M |
| Glow Lifetech | 9.98M |
| Cytophage Technologies | 9.81M |
| Marvel Biosciences | 8.12M |
| PharmaTher Holdings | 7.28M |
| BioVaxys Technology | 7.28M |
| Kane Biotech | 7.26M |